[Bioclusters] Antibacterial Drug Development - Registration Deadline Feb 9th

[Margit Eder]

Register February 9th and Save Up To $200

Download Brochure | Register Today | Submit Poster
(no form required)                                                               
                                                        
Just Some of the Attendees Include: 
 Abbott Labs 
 - Research Chemist

 Achaogen 
 - Scientist
 - Assoc Dir Bus Dev
 - Sr VP Chemistry

 Achillion Pharmaceuticals Inc
 - Dir Antimicrobial Drug Discovery

 Albany Molecular Research Inc
 - Sr Research Sci I

 American Univ
 - Asst Prof

 AMSSINC
 - President

 AstraZeneca Pharmaceuticals Inc
 - Principal Scientist

 AVI Biopharma 
 - VP Bus Dev
 - Sr VP R&D

 Battelle Memorial
 -Research Scientist

 Basilea Pharmaceutica AG
 - CSO

 Biolog Inc
 - Sr Scientist

 Biological Defense Research
 - Dir Deputy Head

 Burnham Institute
 - Staff Scientist
 - Assoc Prof

 Colorado State Univ
 - Microbiology
 - Prof & Assoc Head Graduate Studies & Research

 Ctrs for Disease Control & Prevention
 -  Assoc Dir Lab Science

 CUBRC
 - Dir Microbiology

 Defense Research Establishment Suffield
 - Defence Scientist

 ENANTA Pharmaceuticals
 - Sr VP R&D
 - Project Mgr

 GlaxoSmithKline
 - VP Biology & Infectious Diseases

 John Innes Ctr
 -  Head
 KaloBios Pharmaceuticals Inc
 - VP Research

 Micromyx
 - CEO

 MIGENIX Inc
 - CSO
 - VP Clinical & Regulatory

 Mpex Pharmaceuticals
 - VP Drug Dev

 NIH NIAID
 - Program Officer

 NOVEXEL
 - VP Bus Dev
 - Sr Research Scientist

 Novozymes AS
 - Sr Mgr

 Pacific Northwest Natl Lab
 - Scientist III

 Pfizer Global R&D
 - Assoc Dir Midwest Nonclinical Studies
 - Exec Dir Antibacterials Discovery

 PriCara
 - Therapeutic Area Lead Anti Infectives             

 Rib X Pharmaceuticals Inc
 - Chief Research Officer

 Rohm & Haas Co
 - Tech Mgr

 Southern Methodist Univ
 - Prof

 Theravance
 - VP

 TNO Nutrition & Food Research 
 - Research Mgr
 - Sr Scientist

 Univ Of California San Diego
 - Prof Pediatrics & Pharmacy

 University of Chicago
 - Chemistry

 Univ of Pittsburgh
 - Assoc Prof

 Univ of Saskatchewan
 - Dean

 Uppsala Univ
 - Prof

 VA Medical Ctr Cleveland
 - Section Chief

 Wyeth Research Labs
 - Dir Chemical & Screening Sciences

Keynote Address: 

 The Challenges of Emerging Antimicrobial Resistance

 Fred C. Tenover, Ph.D. (D) A.B.M.M., Associate Director
 for Laboratory Science, Division of Healthcare Quality
 Promotion, Centers for Disease Control And Prevention

Sessions: Genomics-Lessons Learned
Bioinformatics for Predicting Novel Targets
Optimizing b-Lactamase Inhibition
>From Discovery to Delivery-Novel Insights
Resistance is Futile
Novel Targets
Emerging Technologies and Drug Designs

Call For Posters: 
Showcase your research and save an additional $50 by submitting
a poster.  Click here and secure your poster board today.  As an 
added benefit one poster presenter will be given the opportunity
to present a brief oral presentation of their work. The 
presentations will be selected from all abstracts submitted 
prior to the deadline on February 26, 2007.

 Corporate Support:

 

 Lead Sponsoring Publications:

 

 Sponsoring Publications:
   

Sponsorship Opportunities Available:

This conference is specifically targeted for a high-level audience in pharma, biotech industry, and academia and provides many opportunities for collaborations in addition to our variety of available sponsor packages. For complete details on sponsorship opportunities contact:

David Karp at dkarp at healthtech.com, 
phone: 781-972-5483 

For Complete Conference Details Visit: 
www.healthtech.com/2007/bac/index.asp





Distinguished Faculty

David L. Pompliano, Ph.D., Vice President, Biology, Infectious Diseases, Center for Excellence in Drug Discovery, GlaxoSmithKline

Scott D. Mills, Ph.D., Principal Scientist, Infection Discovery,
AstraZeneca R&D

Jason McDermott, M.D., Ph.D., Scientist III, Computational Sciences & Mathematics Division, Pacific Northwest National Lab (Battelle)

Lawrence Wiater, Ph.D., Senior Scientist, Research and Development,
Biolog, Inc.

Michael N. Dudley, Pharm.D., FIDSA, Vice President, Drug Development, Mpex Pharmaceuticals  

Robert Bonomo, M.D., Section Chief, Department of Infectious Diseases, Louis Stokes VAMC

Aranapakam M. Venkatesan, Ph.D., Chemical and Screening Sciences, Wyeth Research

Christine Miossec, Ph.D., Senior Research Scientist, Novexel Nafsika 
Fred C. Tenover, Ph.D. (D) A.B.M.M., Associate Director for Laboratory Science, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention

Georgopapadakou, Ph.D., Vice President Infectious Diseases, MethylGene Inc., Canada

Lynn L. Silver, Ph.D., LL Silver Consulting, LLC

Victor Nizet, M.D., Ph.D., Associate Professor/Chief, Division of Pharmacology & Drug Discovery, University of California, San Diego

Michael J. Pucci, Ph.D., Senior Director, Discovery, Achillion
Pharmaceuticals

Hans-Henrik Kristensen, Ph.D., Senior Manager, Anti-infective
Discovery, Novozymes A/S

Herbert Schweizer Ph.D., Professor, Department of Microbiology, Immunology and Pathology, Colorado State University

Mira Hinman, Ph.D., Associate Research Investigator, Target and Lead Discovery, Global Pharmaceutical R&D, Abbott Laboratories

Christopher Bebbington, Ph.D., Vice President, Research, KaloBios Pharmaceuticals Inc.

Graham Johnson, Ph.D., Chief Research Officer, Discovery, 
Rib-X Pharmaceuticals Inc.

John Cherwonogrodzky, Ph.D., Defence Scientist, Department of National Defence, Canada

If the above information is not of interest to you, please disregard and we apologize for any inconvenience this 
may have caused. To be omitted from further emails, click here or visit www.chiresource.com/rmv.asp 

Cambridge Healthtech Institute | 250 First Avenue, Suite 300 | Needham, MA 02494 |  
Phone:  781.972.5400 or toll free 888.999.6288  |  Fax: 781.972.5425 | Web: www.healthtech.com